在组织再生中使用deferoxamine的应用归因于促进血管生成
Haijun Shen1, Yane Ma1, Yi Qiao1
1Department of Preventive Medicine and Public Health Laboratory Science, School of Medicine, Jiangsu University, 301 Xuefu Road, Zhenjiang 212013, China.
Molecules (Basel, Switzerland)
|May 11, 2024
概括
铁化剂德菲洛胺促进血管生长 (血管生成) 并减少炎症. 这篇评论探讨了其在慢性伤口,骨修复和呼吸系统疾病中的治疗潜力.
科学领域:
- 生物医学工程 生物医学工程
- 药理学 药理学是指药理学的学科.
- 血管生物学 血管生物学
背景情况:
- 德菲洛克萨明是一种FDA批准的铁化剂,具有已确定的抗炎性质.
- 血管功能障碍与许多危及生命的疾病有关.
- 血管新生在组织修复和恒温中发挥着至关重要的作用.
研究的目的:
- 阐明德费洛胺促进血管生成的机制.
- 总结deferoxamine在促进血管健康方面的临床应用.
- 讨论新型的药物输送系统为deferoxamine.
主要方法:
- 审查现有的关于德费洛克萨对血管生成的影响的文献.
- 分析研究的分析调查deferoxamine在伤口愈合,骨修复和呼吸系统条件.
- 检查德费洛克萨药物输送系统.
主要成果:
- 德费洛克萨显示出显著的亲血管性作用.
- 证据支持deferoxamine在治疗慢性伤口和增强骨修复方面的有效性.
- 呼吸系统疾病中的应用正在出现.
结论:
- 德费洛克萨是一种有前途的治疗药物,用于需要血管生成的疾病.
- 优化的药物输送系统可以增强deferoxamine的治疗效果.
- 对德费洛克萨的机制和应用进行进一步的研究是有必要的.
相关概念视频
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K


